Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20161
20192
20203
20213
20221
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6
Completed5
Active, not recruiting4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH3
Novartis Pharmaceuticals3
Alkahest, Inc.1
Alumis Inc1
Amgen1
Beeline Medicines Corporation1
Bristol-Myers Squibb1
Institut de Recherches Internationales Servier1
Jena University Hospital1
Lakefront Biotherapeutics NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases16
Immune System Diseases5
Sjogren's Syndrome5
Arthritis, Rheumatoid3
Connective Tissue Diseases3
Dry Eye Syndromes3
Joint Diseases3
Lupus Erythematosus, Systemic3
Rheumatic Diseases3
Salivary Gland Diseases3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.